Your shopping cart is currently empty

VEGFR-2-IN-43 (compound 16) is an orally active VEGFR2 inhibitor with an IC50 of 39.91 μM, and is suitable for research on wet age-related macular degeneration (w-AMD).
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | VEGFR-2-IN-43 (compound 16) is an orally active VEGFR2 inhibitor with an IC50 of 39.91 μM, and is suitable for research on wet age-related macular degeneration (w-AMD). |
| Targets&IC50 | VEGFR2:39.91 μM |
| In vitro | VEGFR-2-IN-43 (compound 16) exhibits a mild inhibitory effect on LX-2 cell proliferation and a significant inhibitory effect on the proliferation of BaF3-Tel-VEGFR2 cells when administered at concentrations ranging from 0-50 μM over 72 hours. Additionally, VEGFR-2-IN-43 shows a concentration-dependent inhibition of VEGFR2 phosphorylation in HUVEC cells at 0-10 μM for 48 hours. The compound also demonstrates notable plasma stability and moderate liver microsomal stability at a concentration of 1 μM within a 0-120 minute timeframe. |
| In vivo | VEGFR-2-IN-43 (compound 16), when administered to ICR mice at doses of 2/10 mg/kg either intravenously or orally, demonstrates an acceptable oral bioavailability of 20.2% (F = 20.2%). |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.